Martina Rosticci Selected Research

Martina Rosticci Research Topics

7	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2014
6	Hypertension (High Blood Pressure) 01/2017 - 01/2012
4	Gout 06/2015 - 09/2014
3	Overweight 12/2017 - 03/2015
3	Insulin Resistance 03/2017 - 01/2014
2	Fatty Liver 01/2018 - 03/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2016
2	Hypercholesterolemia 12/2017 - 09/2014
2	Dyslipidemias (Dyslipidemia) 12/2017 - 09/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Myalgia 10/2016
1	Mood Disorders (Mood Disorder) 03/2016
1	Snoring 02/2016
1	Vascular Remodeling 01/2016
1	Pre-Eclampsia (Preeclampsia) 10/2015
1	Tachycardia (Tachyarrhythmias) 05/2015
1	Cardiac Arrhythmias (Arrythmia) 05/2015
1	Atrial Fibrillation 05/2015
1	Myocardial Infarction 05/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2015
1	Cognitive Dysfunction 02/2015
1	Carotid Artery Diseases 02/2015
1	Heart Failure 09/2014
1	Coronary Disease (Coronary Heart Disease) 09/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2014
1	Atherosclerosis 01/2014
1	Obesity 01/2014
1	Diabetes Mellitus 01/2014
1	Hypertriglyceridemia 01/2014
1	Essential Hypertension 01/2012

10	Uric Acid (Urate)IBA 01/2018 - 01/2014
8	LipidsIBA 01/2018 - 09/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 09/2014
3	LDL CholesterolIBA 03/2017 - 10/2014
2	coenzyme Q10 (CoQ10)IBA 03/2017 - 10/2016
2	C-Reactive ProteinIBA 06/2016 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 09/2014
2	Gout Suppressants (Antigout Agents)IBA 06/2015 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 09/2014
2	BerberineIBA 03/2015 - 09/2014
2	oxidized low density lipoproteinIBA 02/2015 - 09/2014
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	red yeast riceIBA 03/2017
1	Lipoprotein(a)IBA 01/2017
1	Ezetimibe (Zetia)FDA Link 10/2016
1	Fenofibrate (CiL)FDA LinkGeneric 10/2016
1	Triglycerides (Triacylglycerol)IBA 06/2016
1	EstersIBA 06/2016
1	valyl-prolyl-prolineIBA 04/2016
1	isoleucyl-prolyl-prolineIBA 04/2016
1	SaltsIBA 03/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2015
1	1,4-dihydropyridine (dihydropyridine)IBA 06/2015
1	Chlorogenic AcidIBA 03/2015
1	TocotrienolsIBA 03/2015
1	CholesterolIBA 10/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2014
1	EnzymesIBA 09/2014
1	CreatinineIBA 09/2014
1	Oral ContraceptivesIBA 09/2014
1	Xanthine OxidaseIBA 09/2014
1	lercanidipineIBA 01/2012
1	DiureticsIBA 01/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012
1	Angiotensin Receptor AntagonistsIBA 01/2012

2	Secondary Prevention 05/2017 - 02/2015
1	Activities of Daily Living (ADL) 02/2015
1	Therapeutics 09/2014